Perrigo Co. (PRGO) said it has received final approval from the FDA for its abbreviated new drug application, or ANDA, for calcium acetate capsules, the generic equivalent of Phoslo Gelcaps.
Phoslo Gelcaps are indicated for hyperphosphatemia in patients with end stage kidney disease who are on dialysis.
Perrigo was previously in patent litigation over this product with the brand and the litigation settled in late 2011. The terms of the settlement are confidential.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.